Header Logo

Connection

Srinivas Vourganti to Antibodies, Monoclonal

Back to Details
This is a "connection" page, showing publications Srinivas Vourganti has written about Antibodies, Monoclonal.
Srinivas Vourganti
Connection Strength
0.033
Antibodies, Monoclonal
  1. Epidermal Growth Factor Receptor (EGFR)-targeted Photoimmunotherapy (PIT) for the Treatment of EGFR-expressing Bladder Cancer. Mol Cancer Ther. 2017 10; 16(10):2201-2214.
    View in: PubMed
    Score: 0.033
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.